Dr. Daniel R. Marshak

Member of the Compensation Committee

1957, US-American citizen
Member since 2018, elected until 2026

Education

Ph.D in Biochemistry and Cell Biology, The Rockefeller University, New York, USA; Bachelor in Biochemical Sciences, Harvard University, Cambridge, USA

Professional background

2014 to present	Consultancy for various companies in the Life Sciences, Bio-Pharmaceutical, and Diagnostics industry. Consultant to RADx program of US Government DHHS/NIH/NIBIB for COVID-19 diagnostics
2006 – 2014	PerkinElmer, Inc., USA (NYSE: PKI) In his last role as Senior Vice President and Chief Scientific Officer, he was responsible for all science and technology as well as research and development activities and also led several acquisitions during that time. Additional positions at PerkinElmer: President, Emerging Diagnostics, Waltham, USA and Shanghai, China President, Greater China, Shanghai, China
2000 – 2006	Cambrex Corporation, USA (NYSE: CBM) Vice President and Chief Technology Officer, Biotechnology Vice President Research and Development, Biosciences
1994 – 2000	Sr. Vice President and Chief Scientific Officer, Osiris Therapeutics, Inc
1986 – 1995	Cold Spring Harbor Laboratory, USA Sr. Staff Investigator
1984 – 1986	Staff Fellow, National Institutes of Health, USA

Other activities

RareCyte, Inc.², Member of the Board of Directors

² private company